Radiopharmaceuticals R&D Service

One-stop Service for Radiopharmaceuticals

  • MITRO can provide one-stop CDMO service for radiopharmaceuticals including lead compound screening, radiochemistry, pre-clinical studies, clinical studies and registration.
  • MITRO has rich experience in the development of radiopharmaceuticals and has successfully helped many radiopharmaceutical sponsors to receive clinical approval for both US FDA and China FDA (NMPA).
  • MITRO has helped sponsors register for compounds using different radionuclides:

         ▪ 11 x 177Lu

         ▪ 9 x 18F

         ▪ 3 x 68Ga

         ▪ 2 x 99mTc

         ▪ 2 x 90Y

         ▪ 1 x 64Cu